INS and diabetes mellitus: Since the UK Prospective Diabetes Study [16], it has been assumed that the decline in beta cell functional mass begins before the onset of T2D and proceeds relentlessly thereafter, leading to worsening glycemic control and requiring progressive intensification of diabetes therapy, often culminating in the need for exogenous insulin therapy.